Results 231 to 240 of about 592,213 (353)

Palliative Care: Symptom Management and end of Life Care [PDF]

, 2007
Ministry of Health and Social Welfare, (MoHSW)
core  

Are We Ready With Prevention for Type 1 Diabetes? [PDF]

Diabetes Metab Res Rev
Maines E, Franceschi R, Candia FD, Mozzillo E.   +3 more
europepmc   +1 more source

Flavonoids as Anxiolytics in Animal Tests: Systematic Review, Meta‐Analysis, and Bibliometrical Analysis

Phytotherapy Research, EarlyView.
ABSTRACT Flavonoids are natural secondary metabolites of plants with a basic composition derived from polyphenols that can produce a plethora of different neurophysiological effects, some of which are relevant to anxiety disorders. As such, many flavonoids have been evaluated in behavioral screens in preclinical research on anxiolytics.
Jhennify Albuquerque Machado, Danilo Brandão Araújo, Monica Lima‐Maximino, Diógenes Henrique de Siqueira‐Silva, Bernardo Tomchinsky, Jonathan Cueto‐Escobedo, Juan Francisco Rodríguez‐Landa, Caio Maximino   +7 more
wiley   +1 more source

Harnessing Natural Compounds in Psoriasis: Targeting Cellular Pathways for Effective Therapy

Phytotherapy Research, EarlyView.
Natural compounds act on key cellular pathways in psoriasis by suppressing keratinocyte hyperproliferation, modulating Th17/IL‐17‐mediated immune responses, and reducing oxidative stress. These multi‐target effects highlight their potential as safer adjunctive therapies alongside conventional treatments.
Hye Jin Lee, Yu Jin So, Il‐Joo Jo, Ji Yong Jang, Tae Han Yook, Jun Ho Lee, Sung Wook Kim, Kangwook Lee, Soo Jung Park, Gabsik Yang   +9 more
wiley   +1 more source

Integrating network pharmacology, molecular docking and experimental validation to explore therapeutic targets for alleviating allergic rhinitis with anxiety and depressive behaviors. [PDF]

RSC Adv
Lin Y, Liu S, Zhu Z, Yang J, Huang P, Liu Y, Luo W.   +6 more
europepmc   +1 more source

Ashwagandha: Is It Safe? Part 2: A Preclinical Evidence Review

Phytotherapy Research, EarlyView.
ABSTRACT The preclinical evidence for the safety of ashwagandha (Withania somnifera (L.) Dunal, AS) is reviewed, and its preparations (extracts) and constituents, from the general toxicity in animal models to in vitro and cell culture studies, which may elucidate mechanisms of action and explain clinical case reports.
Elizabeth M. Williamson, Thomas Brendler
wiley   +1 more source

The use of enforcement to combat begging and street drinking in England: a high risk strategy? [PDF]

, 2008
Fitzpatrick, Suzanne, Johnsen, Sarah
core  

Correction of Vitamin D Deficiency Improves PTSD Symptoms in Gulf War Veterans. [PDF]

Brain Sci
Kesavan C, Strong DD, Strong RM.
europepmc   +1 more source

Safety of 12‐Months Administration of Ashwagandha (Withania somnifera) Standardized Root Extract in Healthy Adults: A Prospective, Observational Study

Phytotherapy Research, EarlyView.
ABSTRACT Ashwagandha, an adaptogen, is an important herb of Ayurveda used as a Rasayana for its various health benefits. This prospective, multi‐center, observational clinical study evaluates the safety (clinical and laboratory) of a standardized Ashwagandha Root Extract (ARE) on long‐term administration over 12 months. Male and female adults (N = 191)
Jaising Salve, Sanjeev Kale, Banwari Lal Prajapati, Adele Sparavigna, Mark Savant, John Ademola, Deepak Langade   +6 more
wiley   +1 more source

Severe alcohol use and COVID-19: implications for physical and mental health. [PDF]

Front Psychiatry
Calleja-Conde J, Echeverry-Alzate V, Sánchez-Diez S, Giné E, Bühler KM.   +4 more
europepmc   +1 more source